Clinical Trials Information System (CTIS) reaches major milestone towards go-live and application of the Clinical Trial Regulation

EMA’s Management Board confirmed that the clinical trial EU Portal and Database, one of the main deliverables of the Clinical Trial Regulation and the key component of the Clinical Trial Information System (CTIS), is now fully functional and on track to go live by 31 January 2022. The Board confirmed that it has verified that the system meets the agreed requirements during an extraordinary […]

Read More "Clinical Trials Information System (CTIS) reaches major milestone towards go-live and application of the Clinical Trial Regulation"

EU regulators expand use of remote source data verification in clinical trials during the COVID-19 pandemic

The latest update to the European Commission and European Medicines Agency’s guidance on managing clinical trials conducted during the COVID-19 pandemic (V4 04Feb21) expands the use and scope of remote source data verification (rSDV) in clinical trials. Now, in addition to trials involving the treatment or prevention of COVID-19, remote SDV may be considered for […]

Read More "EU regulators expand use of remote source data verification in clinical trials during the COVID-19 pandemic"

GUIDANCE FOR SPONSORS ON THE USE OF ELECTRONIC INFORMED CONSENT IN INTERVENTIONAL CLINICAL TRIALS IN BELGIUM

On 30 September 2020, the Working group Informed Consent published version 1.0 of the guidance document on the use of e-consent in Belgium. Please find hereby the link to the document: https://overlegorganen.gezondheid.belgie.be/sites/default/files/content/guidance_on_use_of_e-icf_vf.pdf

Read More "GUIDANCE FOR SPONSORS ON THE USE OF ELECTRONIC INFORMED CONSENT IN INTERVENTIONAL CLINICAL TRIALS IN BELGIUM"

On 30th April, FAMHP published V2 of the Addendum to the Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic

Please note that this document is to be read in conjunction with the latest version of the European guidance and that the national guidance provides some more detailed clarifications and additional topics of interest. This text was written by the FAMHP, the Clinical Trial College and the Belgian association of Research Ethics Committees (BAREC).The information […]

Read More "On 30th April, FAMHP published V2 of the Addendum to the Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic"

Draft points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials

On 25th March, EMA issued a draft guidance for consultation with deadline for comments on 25th April. https://www.ema.europa.eu/en/documents/scientific-guideline/points-consider-implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical_en.pdf

Read More "Draft points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials"

Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

On 28th of April, The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA) have published version 3 of their guidance to sponsors on how to manage clinical trials during the COVID-19 (Coronavirus) pandemic. Key changes from v2 (27-03-2020): distributor to trial participant IMP shipment, monitoring, remote source data verification […]

Read More "Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic"

Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019

Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019 Date & Time: 17 April 2019 from 3:30 PM to 5:00 PM (CET)    Attendance Fee: € 90,- for EUCROF non-members € 60,- for EUCROF members using the code DATA0417 Register here    

Read More "Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019"

Need more information ?

BECRO

SINT GOEDELEPLEIN – 5  – PLACE SAINTE-GUDULE
B-1000 BRUSSELS / BELGIUM
PHONE: +32 (0)2 504 07 21
E-MAIL: INFO@BECRO.BE

© 2018 BECRO – ALL RIGHTS RESERVED

Octopix + WordPress = ♥ | Design by Simplexity